Related Experiment Video
Updated: May 30, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials
Bruno Vellas1, Alain Pesce, Philippe H Robert
1Department of Geriatrics, INSERM U558, Toulouse University Hospital Center, Toulouse, France.
Abstract:
The recruitment and retention of patients are among the greatest challenges currently being faced by researchers who conduct Alzheimer's disease (AD) clinical trials. To discuss these challenges and other major issues associated with clinical research in AD, an international workshop was organized by the Association Monégasque pour la recherche sur la Maladie d'Alzheimer at Monte Carlo, Monaco, in February 2010, with the participation of leading research experts in the field of Alzheimer's. Key topics discussed were as follows: (1) the selection, recruitment, and retention of clinical trial subjects; (2) international co-operation among researchers; and (3) patient rights and informed consent for participants in clinical trials. This article highlights some of the challenges faced by investigators when conducting clinical trials in AD, and it also offers some recommendations aimed at overcoming these challenges.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Clinical Trials: Overview
Alzheimer Disease ll: Pathophysiology
Clinical Trials
There are four phases in a clinical trial. A phase one...